T9	B-Entity	B-Entity	0	5	Human	Human	B-NP	JJ	O	6	NMOD	O
T9	I-Entity	I-Entity	6	9	MHC	MHC	I-NP	NN	B-DNA	6	NMOD	B-DNA
T9	I-Entity	I-Entity	10	15	class	class	I-NP	NN	I-DNA	6	NMOD	I-DNA
T9	I-Entity	I-Entity	16	18	II	II	I-NP	CD	I-DNA	6	NMOD	I-DNA
T9	I-Entity	I-Entity	19	23	gene	gene	I-NP	NN	I-DNA	6	NMOD	I-DNA
O	O	O	24	37	transcription	transcription	I-NP	NN	O	15	NMOD	O
O	O	O	38	46	directed	direct	B-VP	VBN	O	6	NMOD	O
O	O	O	47	49	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	50	53	the	the	B-NP	DT	O	11	NMOD	O
T10	B-Entity	B-Entity	54	62	carboxyl	carboxyl	I-NP	NN	B-protein	11	NMOD	B-protein
T10	I-Entity	I-Entity	63	71	terminus	terminus	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	72	74	of	of	B-PP	IN	O	11	NMOD	O
T1	B-Protein	B-Protein	75	80	CIITA	CIITA	B-NP	NN	B-protein	12	PMOD	B-protein
O	O	O	80	81	,	,	O	,	O	15	P	O
O	O	O	82	85	one	one	B-NP	CD	O	0	ROOT	O
O	O	O	86	88	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	89	92	the	the	B-NP	DT	O	19	NMOD	O
T11	B-Entity	B-Entity	93	102	defective	defective	I-NP	JJ	B-DNA	19	NMOD	B-DNA
T11	I-Entity	I-Entity	103	108	genes	gene	I-NP	NNS	I-DNA	16	PMOD	I-DNA
O	O	O	109	111	in	in	B-PP	IN	O	19	NMOD	O
T12	B-Entity	B-Entity	112	116	type	type	B-NP	NN	O	26	NMOD	O
T12	I-Entity	I-Entity	117	119	II	II	I-NP	CD	O	26	NMOD	O
T12	I-Entity	I-Entity	120	123	MHC	MHC	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	124	132	combined	combined	I-NP	JJ	O	26	NMOD	O
O	O	O	133	139	immune	immune	I-NP	JJ	O	26	NMOD	O
O	O	O	140	150	deficiency	deficiency	I-NP	NN	O	20	PMOD	O
O	O	O	150	151	.	.	O	.	O	15	P	O

T13	B-Entity	B-Entity	153	157	Type	Type	B-NP	NN	B-protein	5	NMOD	B-protein
T13	I-Entity	I-Entity	158	160	II	II	I-NP	CD	I-protein	5	NMOD	I-protein
T13	I-Entity	I-Entity	161	166	major	major	I-NP	JJ	I-protein	5	NMOD	I-protein
T13	I-Entity	I-Entity	167	185	histocompatibility	histocompatibility	I-NP	NN	I-protein	5	NMOD	I-protein
T13	I-Entity	I-Entity	186	193	complex	complex	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	O	194	202	combined	combined	I-NP	JJ	O	8	NMOD	O
O	O	O	203	209	immune	immune	I-NP	JJ	O	8	NMOD	O
O	O	O	210	220	deficiency	deficiency	I-NP	NN	O	19	SUB	O
O	O	O	221	222	(	(	O	(	O	18	DEP	O
T14	B-Entity	B-Entity	222	226	type	type	B-NP	NN	O	13	NMOD	O
T14	I-Entity	I-Entity	227	229	II	II	I-NP	CD	O	13	NMOD	O
T14	I-Entity	I-Entity	230	233	MHC	MHC	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	234	237	CID	CID	I-NP	NN	O	17	NMOD	O
O	O	O	238	240	or	or	O	CC	O	17	NMOD	O
O	O	O	241	245	bare	bare	B-NP	JJ	O	17	NMOD	O
O	O	O	246	256	lymphocyte	lymphocyte	I-NP	NN	O	17	NMOD	O
O	O	O	257	265	syndrome	syndrome	I-NP	NN	O	18	DEP	O
O	O	O	265	266	)	)	O	)	O	8	NMOD	O
O	O	O	267	269	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	270	271	a	a	B-NP	DT	O	23	NMOD	O
O	O	O	272	282	congenital	congenital	I-NP	JJ	O	23	NMOD	O
O	O	O	283	299	immunodeficiency	immunodeficiency	I-NP	NN	O	23	NMOD	O
O	O	O	300	307	disease	disease	I-NP	NN	O	19	PRD	O
O	O	O	308	321	characterized	characterize	B-VP	VBN	O	23	NMOD	O
O	O	O	322	324	by	by	B-PP	IN	O	24	VMOD	O
O	O	O	325	331	absent	absent	B-NP	JJ	O	30	NMOD	O
T15	B-Entity	B-Entity	332	335	MHC	MHC	I-NP	NN	B-protein	28	NMOD	B-protein
T15	I-Entity	I-Entity	336	341	class	class	I-NP	NN	I-protein	30	NMOD	I-protein
T15	I-Entity	I-Entity	342	344	II	II	I-NP	CD	I-protein	28	NMOD	I-protein
O	O	O	345	355	expression	expression	I-NP	NN	O	25	PMOD	O
O	O	O	355	356	.	.	O	.	O	19	P	O

O	O	O	357	361	Four	Four	B-NP	CD	O	4	NMOD	O
O	O	O	362	370	distinct	distinct	I-NP	JJ	O	4	NMOD	O
O	O	O	371	386	complementation	complementation	I-NP	NN	O	4	NMOD	O
O	O	O	387	393	groups	group	I-NP	NNS	O	5	SUB	O
O	O	O	394	398	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	399	403	been	be	I-VP	VBN	O	5	VC	O
O	O	O	404	414	identified	identify	I-VP	VBN	O	6	VC	O
O	O	O	414	415	.	.	O	.	O	5	P	O

O	O	O	416	424	Recently	Recently	B-ADVP	RB	O	13	VMOD	O
O	O	O	424	425	,	,	O	,	O	13	P	O
O	O	O	426	429	the	the	B-NP	DT	O	5	NMOD	O
T16	B-Entity	B-Entity	430	439	defective	defective	I-NP	JJ	B-DNA	5	NMOD	B-DNA
T16	I-Entity	I-Entity	440	444	gene	gene	I-NP	NN	I-DNA	13	SUB	I-DNA
O	O	O	445	447	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	448	453	group	group	B-NP	NN	O	12	NMOD	O
O	O	O	454	456	II	II	I-NP	CD	O	12	NMOD	O
T17	B-Entity	B-Entity	457	461	type	type	I-NP	NN	O	12	NMOD	O
T17	I-Entity	I-Entity	462	464	II	II	I-NP	CD	O	12	NMOD	O
T17	I-Entity	I-Entity	465	468	MHC	MHC	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	469	472	CID	CID	I-NP	NN	O	6	PMOD	O
O	O	O	473	476	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	477	481	been	be	I-VP	VBN	O	13	VC	O
O	O	O	482	490	isolated	isolate	I-VP	VBN	O	14	VC	O
O	O	O	491	494	and	and	O	CC	O	15	VMOD	O
O	O	O	495	501	termed	term	B-VP	VBN	O	15	VMOD	O
T2	B-Protein	B-Protein	502	507	CIITA	CIITA	B-NP	NN	B-protein	17	VMOD	B-protein
O	O	O	507	508	.	.	O	.	O	13	P	O

O	O	O	509	513	Here	Here	B-ADVP	RB	O	4	VMOD	O
O	O	O	513	514	,	,	O	,	O	4	P	O
O	O	O	515	517	we	we	B-NP	PRP	O	4	SUB	O
O	O	O	518	529	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	530	534	that	that	B-SBAR	IN	O	4	VMOD	O
T3	B-Protein	B-Protein	535	540	CIITA	CIITA	B-NP	NN	B-protein	7	SUB	B-protein
O	O	O	541	543	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	O	544	546	an	an	B-NP	DT	O	12	NMOD	O
T18	B-Entity	B-Entity	547	550	MHC	MHC	I-NP	NN	B-DNA	12	NMOD	B-DNA
T18	I-Entity	I-Entity	551	556	class	class	I-NP	NN	I-DNA	12	NMOD	I-DNA
T18	I-Entity	I-Entity	557	559	II	II	I-NP	CD	I-DNA	12	NMOD	I-DNA
T18	I-Entity	I-Entity	560	564	gene	gene	I-NP	NN	I-DNA	16	NMOD	I-DNA
O	O	O	564	565	-	-	B-NP	HYPH	O	16	P	O
O	O	O	565	573	specific	specific	I-NP	JJ	O	16	NMOD	O
O	O	O	574	587	transcription	transcription	I-NP	NN	O	16	NMOD	O
O	O	O	588	597	activator	activator	I-NP	NN	O	7	PRD	O
O	O	O	597	598	.	.	O	.	O	4	P	O

O	O	O	599	602	The	The	B-NP	DT	O	4	NMOD	O
O	O	O	603	616	transcription	transcription	I-NP	NN	O	4	NMOD	O
O	O	O	617	627	activation	activation	I-NP	NN	O	4	NMOD	O
O	O	O	628	636	function	function	I-NP	NN	O	5	SUB	O
O	O	O	637	639	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	640	648	provided	provide	I-VP	VBN	O	5	VC	O
O	O	O	649	651	by	by	B-PP	IN	O	6	VMOD	O
O	O	O	652	655	the	the	B-NP	DT	O	13	NMOD	O
T19	B-Entity	B-Entity	656	657	N	N	I-NP	NN	B-protein	13	NMOD	B-protein
T19	I-Entity	I-Entity	657	658	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T19	I-Entity	I-Entity	658	666	terminal	terminal	I-NP	JJ	I-protein	13	NMOD	I-protein
T19	I-Entity	I-Entity	667	673	acidic	acidic	I-NP	JJ	I-protein	13	NMOD	I-protein
T19	I-Entity	I-Entity	674	680	domain	domain	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	681	682	(	(	O	(	O	20	DEP	O
T20	B-Entity	B-Entity	682	687	amino	amino	B-NP	NN	B-protein	16	NMOD	B-protein
T20	I-Entity	I-Entity	688	693	acids	acid	I-NP	NNS	I-protein	20	DEP	I-protein
T20	I-Entity	I-Entity	694	696	26	26	B-NP	CD	I-protein	16	NMOD	I-protein
T20	I-Entity	I-Entity	696	697	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T20	I-Entity	I-Entity	697	700	137	137	I-NP	CD	I-protein	16	NMOD	I-protein
O	O	O	700	701	)	)	O	)	O	13	NMOD	O
O	O	O	701	702	,	,	O	,	O	13	P	O
O	O	O	703	708	which	which	B-NP	WDT	O	13	NMOD	O
O	O	O	709	711	is	be	B-VP	VBZ	O	22	SBAR	O
O	O	O	712	726	experimentally	experimentally	B-ADJP	RB	O	25	AMOD	O
O	O	O	727	739	exchangeable	exchangeable	I-ADJP	JJ	O	23	PRD	O
O	O	O	740	744	with	with	B-PP	IN	O	25	AMOD	O
O	O	O	745	746	a	a	B-NP	DT	O	33	NMOD	O
T21	B-Entity	B-Entity	747	759	heterologous	heterologous	I-NP	JJ	B-protein	30	NMOD	B-protein
T21	I-Entity	I-Entity	760	765	viral	viral	I-NP	JJ	I-protein	30	NMOD	I-protein
T21	I-Entity	I-Entity	766	779	transcription	transcription	I-NP	NN	I-protein	33	NMOD	I-protein
T21	I-Entity	I-Entity	779	780	-	-	O	HYPH	I-protein	33	NMOD	I-protein
T21	I-Entity	I-Entity	780	790	activating	activate	B-VP	VBG	I-protein	33	NMOD	I-protein
T21	I-Entity	I-Entity	791	797	domain	domain	B-NP	NN	I-protein	26	PMOD	I-protein
O	O	O	797	798	.	.	O	.	O	5	P	O

O	O	O	799	802	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	803	814	specificity	specificity	I-NP	NN	O	19	SUB	O
O	O	O	815	817	of	of	B-PP	IN	O	2	NMOD	O
T4	B-Protein	B-Protein	818	823	CIITA	CIITA	B-NP	NN	B-protein	3	PMOD	B-protein
O	O	O	824	827	for	for	B-PP	IN	O	2	NMOD	O
O	O	O	828	833	three	three	B-NP	CD	O	17	NMOD	O
O	O	O	834	839	major	major	I-NP	JJ	O	6	NMOD	O
T22	B-Entity	B-Entity	840	843	MHC	MHC	I-NP	NN	B-DNA	11	NMOD	B-DNA
T22	I-Entity	I-Entity	844	849	class	class	I-NP	NN	I-DNA	11	NMOD	I-DNA
T22	I-Entity	I-Entity	850	852	II	II	B-NP	CD	I-DNA	11	NMOD	I-DNA
T22	I-Entity	I-Entity	853	858	genes	gene	I-NP	NNS	I-DNA	6	NMOD	I-DNA
O	O	O	858	859	,	,	O	,	O	17	P	O
T23	B-Entity	B-Entity	860	862	DR	DR	B-NP	NN	B-DNA	17	NMOD	B-DNA
O	O	O	862	863	,	,	O	,	O	17	P	O
T24	B-Entity	B-Entity	864	866	DQ	DQ	B-NP	NN	B-DNA	17	NMOD	B-DNA
O	O	O	867	870	and	and	I-NP	CC	O	17	NMOD	O
T25	B-Entity	B-Entity	871	873	DP	DP	I-NP	NN	B-DNA	5	PMOD	B-DNA
O	O	O	873	874	,	,	O	,	O	2	P	O
O	O	O	875	877	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	878	886	mediated	mediate	I-VP	VBN	O	19	VC	O
O	O	O	887	889	by	by	B-PP	IN	O	20	VMOD	O
O	O	O	890	893	its	its	B-NP	PRP$	O	27	NMOD	O
O	O	O	894	903	remaining	remain	I-NP	VBG	O	27	NMOD	O
T26	B-Entity	B-Entity	904	905	C	C	I-NP	NN	B-protein	27	NMOD	B-protein
T26	I-Entity	I-Entity	905	906	-	-	I-NP	HYPH	I-protein	27	NMOD	I-protein
T26	I-Entity	I-Entity	906	914	terminal	terminal	I-NP	JJ	I-protein	27	NMOD	I-protein
T26	I-Entity	I-Entity	915	923	residues	residue	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	O	924	925	(	(	O	(	O	34	DEP	O
T27	B-Entity	B-Entity	925	930	amino	amino	B-NP	NN	B-protein	30	NMOD	B-protein
T27	I-Entity	I-Entity	931	936	acids	acid	I-NP	NNS	I-protein	34	DEP	I-protein
T27	I-Entity	I-Entity	937	940	317	317	B-NP	CD	I-protein	30	NMOD	I-protein
T27	I-Entity	I-Entity	940	941	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T27	I-Entity	I-Entity	941	945	1130	1130	I-NP	CD	I-protein	30	NMOD	I-protein
O	O	O	945	946	)	)	O	)	O	27	NMOD	O
O	O	O	946	947	.	.	O	.	O	19	P	O

O	O	O	948	951	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	952	967	transactivation	transactivation	I-NP	NN	O	24	SUB	O
O	O	O	968	970	of	of	B-PP	IN	O	2	NMOD	O
T28	B-Entity	B-Entity	971	979	multiple	multiple	B-NP	JJ	B-DNA	6	NMOD	B-DNA
T28	I-Entity	I-Entity	980	983	cis	cis	I-NP	NN	I-DNA	6	NMOD	I-DNA
T28	I-Entity	I-Entity	984	992	elements	element	I-NP	NNS	I-DNA	11	NMOD	I-DNA
O	O	O	992	993	,	,	O	,	O	11	P	O
O	O	O	994	1004	especially	especially	B-NP	RB	O	11	NMOD	O
T29	B-Entity	B-Entity	1005	1006	S	S	I-NP	NN	O	11	NMOD	O
O	O	O	1007	1010	and	and	I-NP	CC	O	11	NMOD	O
T30	B-Entity	B-Entity	1011	1013	X2	X2	I-NP	NN	B-DNA	3	PMOD	B-DNA
O	O	O	1013	1014	,	,	O	,	O	11	P	O
O	O	O	1015	1017	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1018	1021	the	the	B-NP	DT	O	18	NMOD	O
T5	B-Protein	B-Protein	1022	1024	DR	DR	I-NP	NN	B-DNA	18	NMOD	B-DNA
T5	I-Protein	I-Protein	1025	1030	alpha	alpha	I-NP	NN	I-DNA	18	NMOD	I-DNA
T31	B-Entity	B-Entity	1031	1039	proximal	proximal	I-NP	JJ	I-DNA	18	NMOD	I-DNA
T31	I-Entity	I-Entity	1040	1048	promoter	promoter	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	O	1049	1051	in	in	B-PP	IN	O	18	NMOD	O
O	O	O	1052	1057	group	group	B-NP	NN	B-cell_line	23	NMOD	B-cell_line
O	O	O	1058	1060	II	II	I-NP	CD	I-cell_line	23	NMOD	I-cell_line
O	O	O	1061	1064	CID	CID	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	O	1065	1070	cells	cell	I-NP	NNS	I-cell_line	19	PMOD	I-cell_line
O	O	O	1071	1073	is	be	B-VP	VBZ	O	0	ROOT	O
T6	B-Protein	B-Protein	1074	1079	CIITA	CIITA	B-NP	NN	B-protein	26	AMOD	B-protein
O	O	O	1080	1089	dependent	dependent	B-ADJP	JJ	O	24	PRD	O
O	O	O	1089	1090	.	.	O	.	O	24	P	O

O	O	O	1091	1096	Since	Since	B-SBAR	IN	O	15	VMOD	O
T7	B-Protein	B-Protein	1097	1102	CIITA	CIITA	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	1103	1117	overexpression	overexpression	I-NP	NN	O	7	SUB	O
O	O	O	1118	1120	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	1121	1127	normal	normal	B-NP	JJ	B-cell_type	6	NMOD	B-cell_type
O	O	O	1128	1133	cells	cell	I-NP	NNS	I-cell_type	4	PMOD	I-cell_type
O	O	O	1134	1137	did	do	B-VP	VBD	O	1	SBAR	O
O	O	O	1138	1141	not	not	I-VP	RB	O	7	VMOD	O
O	O	O	1142	1150	increase	increase	I-VP	VB	O	7	VC	O
T32	B-Entity	B-Entity	1151	1156	class	class	B-NP	NN	O	12	NMOD	O
T32	I-Entity	I-Entity	1157	1159	II	II	I-NP	CD	O	12	NMOD	O
O	O	O	1160	1170	expression	expression	I-NP	NN	O	9	OBJ	O
O	O	O	1170	1171	,	,	O	,	O	15	P	O
O	O	O	1172	1174	we	we	B-NP	PRP	O	15	SUB	O
O	O	O	1175	1182	propose	propose	B-VP	VBP	O	0	ROOT	O
O	O	O	1183	1187	that	that	B-SBAR	IN	O	15	VMOD	O
O	O	O	1188	1198	initiation	initiation	B-NP	NN	O	21	SUB	O
O	O	O	1199	1201	of	of	B-PP	IN	O	17	NMOD	O
T8	B-Protein	B-Protein	1202	1207	CIITA	CIITA	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	1208	1218	expression	expression	I-NP	NN	O	18	PMOD	O
O	O	O	1219	1225	serves	serve	B-VP	VBZ	O	16	SBAR	O
O	O	O	1226	1228	as	as	B-PP	IN	O	21	VMOD	O
O	O	O	1229	1232	the	the	B-NP	DT	O	27	NMOD	O
O	O	O	1233	1235	on	on	I-NP	RB	O	25	VMOD	O
O	O	O	1235	1236	-	-	B-VP	HYPH	O	27	NMOD	O
O	O	O	1236	1239	off	off	B-PRT	RP	O	25	VMOD	O
O	O	O	1240	1246	switch	switch	B-NP	NN	O	22	PMOD	O
O	O	O	1246	1247	,	,	O	,	O	21	P	O
O	O	O	1248	1253	while	while	B-SBAR	IN	O	21	VMOD	O
O	O	O	1254	1266	availability	availability	B-NP	NN	O	37	SUB	O
O	O	O	1267	1269	of	of	B-PP	IN	O	30	NMOD	O
O	O	O	1270	1280	downstream	downstream	B-NP	JJ	O	35	NMOD	O
O	O	O	1281	1291	interactor	interactor	I-NP	NN	O	35	NMOD	O
O	O	O	1291	1292	(	(	I-NP	(	O	35	NMOD	O
O	O	O	1292	1293	s	s	I-NP	NNS	O	31	PMOD	O
O	O	O	1293	1294	)	)	O	)	O	35	NMOD	O
O	O	O	1295	1301	limits	limit	B-VP	VBZ	O	29	SBAR	O
O	O	O	1302	1315	transcription	transcription	B-NP	NN	O	37	OBJ	O
O	O	O	1315	1316	.	.	O	.	O	15	P	O
